Microplastics have emerged as one of the most widely discussed environmental contaminants of our time. Regardless of where we live, daily exposure to microplastics has become virtually unavoidable—these tiny plastic particles are present in the air we breathe, the water we drink, and the environments we inhabit. As researchers work to better understand the sources, transport pathways, and impacts of microplastics, the demand for reliable microplastic analysis methods continues to grow.While techniques such as FTIR and Raman spectroscopy have become standard tools for identifying microplastics, their utility is limited for smaller particles (i.e. nanoplastics) and in complex matrices. More advanced microplastic analysis methods can provide a deeper understanding of what these particles contain and how they may change over time in the environment.<div><h3>The Limits of Spectroscopic Microplastic Analysis Methods</h3>Fourier-Transform Infrared (FTIR) and Raman spectroscopy are widely used microplastic analysis methods because they can identify polymer types by measuring how electromagnetic radiation interacts with a material. These techniques are valuable for determining whether a particle is polyethylene, polypropylene, polystyrene, or another common plastic. For many studies, this information is sufficient to confirm the presence of microplastics, especially in clean samples with sufficient microplastic density.However, <a target="_blank" rel="noopener noreferrer" href="https://www.leco.com/application/environmental/">environmental samples</a> are rarely clean and compositionally simple. Microplastic particles can become weathered and obscured by other materials in the environment, making their accurate identification with spectroscopy difficult. Additionally, if researchers want to understand what additives, degradation products, or pollutants are associated with the plastic, particle identification alone is not enough. Thus, FTIR and Raman spectroscopy methods alone struggle to thoroughly characterize these complex chemical components, particularly in challenging environmental matrices. As questions surrounding microplastic exposure become increasingly important, researchers require analytical techniques capable of examining the chemistry of a sample in greater detail, not simply confirming the presence of the physical particle itself.</div><div><h3>Thermal Desorption and Pyrolysis GCxGC-TOFMS For Deeper Microplastic Analysis</h3>Thermal Desorption (TD) and Pyrolysis (Py) coupled with comprehensive two-dimensional gas chromatography and time-of-flight mass spectrometry (<a target="_blank" rel="noopener noreferrer" href="https://www.leco.com/core-analysis/gc-and-gc-ms/">GCxGC-TOFMS</a>) offer a powerful alternative for investigating nano- and microplastics in complex samples. These techniques provide complementary information about sample composition.&nbsp;Thermal desorption releases volatile and adsorbed compounds, including environmental contaminants, degradation products, and VOCs associated with microplastic particles. This can reveal important information about chemicals present within or on the plastic.Pyrolysis thermally deconstructs the polymeric material, breaking it into GC-amenable characteristic degradation compounds. These compounds act as chemical markers that can be used to identify the various polymers present. When analyzing complex or heavily weathered microplastics that may be difficult to characterize using traditional spectroscopic techniques, pyrolysis is particularly advantageous.The most significant benefit comes from pairing these techniques with comprehensive two-dimensional gas chromatography. Environmental samples often contain hundreds or even thousands of compounds that coelute in 1D GC-MS, making it difficult or impossible to identify each compound. GCxGC provides significantly greater separation capability, helping analysts distinguish important polymer markers from background matrix components. This enhanced separation improves the mass spectrometer’s ability to identify characteristic polymer pyrolysis products, even in highly complex environmental samples. As a result, researchers can detect and identify challenging microplastics without the extensive purification steps often required by other analytical workflows.Another unique advantage of this approach is that thermal desorption and pyrolysis can be used in series on the same sample. Together, they create a more complete chemical profile of the sample.</div><div><h3>A Powerful Microplastics Analysis Workflow for Deeper Insight into the Effects on Our Environment</h3>FTIR and Raman spectroscopy remain valuable tools for rapid screening and flagging samples containing microplastic particles. However, by combining thermal desorption, pyrolysis, and GCxGC-TOFMS, analysts can obtain a much more comprehensive view of plastics in their samples and their environmental implications. As environmental research continues to advance and concerns surrounding microplastic contamination grow, researchers will increasingly require information that extends beyond answering the question,&nbsp;“What plastic is present?”&nbsp;&nbsp;Ultimately, this deeper level of characterization can provide new insights into the environmental fate of microplastics and help scientists better understand their potential impacts on ecosystems and human exposure.</div>

Surpassing the Limits of Traditional Microplastic Analysis Methods with Thermal Desorption and Pyrolysis GCxGC-TOFMS

Oligonucleotide and mRNA Analysis Resource Roundup

NIST26 introduces integrated chromatogram processing, deconvolution, and library searching for EI GC-MS and LC-MS/MS data, but the workflow begins with one essential requirement: chromatographic data must be available in the mzML format. In his presentation <a target="_blank" rel="noopener noreferrer" href="https://labrulez.com/pdf/Conversion_to_mz_ML_63e134bb34.pdf">Conversion to mzML Format for NIST26 Chromatogram Processing</a>, James Little of Mass Spec Interpretation Services explains how vendor data can be converted to mzML using either instrument-vendor software or the freely available MSConvert tool from ProteoWizard, and highlights several settings that are critical for successful processing in NIST26.<h4>NIST26 Chromatogram processing requires mzML</h4>For the chromatogram-processing workflow described in the presentation, mzML is the accepted input format. Proprietary LC-MS or GC-MS data therefore need to be converted before they can be loaded into the NIST26 chromatogram-processing environment.There are two principal ways to obtain an mzML file:<ul><li>conversion using software supplied by the instrument manufacturer,</li><li>conversion using MSConvert, which is included in the free ProteoWizard software package.</li></ul>Using an open format such as mzML also provides a practical way to move mass spectrometry data between different software environments without relying exclusively on proprietary vendor formats.<h4>Using ProteoWizard and MSConvert</h4>MSConvert is installed as part of the complete ProteoWizard package rather than as a separate application. After installing ProteoWizard, users can access either the graphical MSConvert interface or the command-line version.The presentation recommends the stable release for routine work, while noting that newer or nightly builds may sometimes provide improved support for recently introduced vendor formats or additional control over data-processing filters. This can be particularly relevant when handling vendor files in which centroiding behavior or peak picking requires closer attention.For most users, the graphical interface provides a straightforward route from proprietary raw data to an mzML file suitable for further NIST26 processing.<h4>Start by selecting mzML as the output format</h4>The first step in MSConvert is to select the source file or dataset using the Browse function.The software supports a broad range of mass spectrometry data formats, and the file-selection window can either be restricted to a particular vendor format or set to display any supported spectral format.After selecting the source data, the output format must be set to mzML. The screenshots in the presentation show this setting directly in the MSConvert options panel before the conversion is started.The user can also select the destination folder and other file-output options before adding the selected dataset to the conversion queue.<h4>Add the data and start the conversion</h4>Once the source file and output settings have been selected, the file is added to the conversion list using the Add command.The conversion itself is then launched with Start.For simple datasets that are already stored in the correct spectral representation, this may be all that is required. However, James Little emphasizes an additional requirement that is particularly important for NIST26: the data must be centroided.<h4>Centroided data are required</h4>According to the presentation, profile-mode data are not acceptable for this NIST26 chromatogram-processing workflow. The spectra must instead be in centroided, or peak-picked, form.Profile spectra contain the full measured shape of each mass spectral signal across the m/z axis. Centroided data reduce these profiles to discrete peaks represented by their characteristic m/z and intensity values.If the original vendor data are still in profile mode, centroiding can be performed during conversion by adding the Peak Picking filter in MSConvert.This means that the conversion step can perform two operations at once:vendor raw data → centroiding / peak picking → mzMLThe resulting mzML file can then be used as input for NIST26 chromatogram processing.<h4>Peak Picking must be the first filter</h4>One of the most important practical details in the presentation is the position of the Peak Picking operation in the MSConvert filter sequence.If centroiding is required, Peak Picking must be the first algorithm or filter in the list. Placing another processing function before it can interfere with the intended conversion workflow.MSConvert allows the user to select the Peak Picking filter, define the relevant MS levels, and add it to the processing sequence before starting conversion. The example shown in the presentation applies vendor-based peak picking to selected MS levels.If there is uncertainty about whether the source data are already centroided, the Peak Picking filter can still be included. According to the presentation, applying it to data that are already centroided does not alter the file unnecessarily.This provides a useful safeguard when the acquisition mode of an older dataset is uncertain.<h4>Selecting the appropriate MS levels</h4>Peak picking does not necessarily have to be applied identically to every spectrum in a dataset. MSConvert allows users to specify the MS levels to which the filter should be applied.This is especially relevant for LC-MS/MS data, where a file can contain both precursor-level MS spectra and tandem MS spectra.The conversion settings should therefore reflect the way the original data were acquired and how those data will subsequently be processed in NIST26.<h4>Be aware of changes in file size</h4>The presentation also notes that converted files may become substantially different in size from the original vendor files.This is worth considering when working with large LC-MS/MS datasets or processing batches of chromatograms. The size of the resulting mzML file can depend on the original acquisition mode, centroiding, compression settings, the number of MS levels, and other output parameters.Storage requirements should therefore be considered before converting large collections of raw data.<h4>A simple workflow for preparing data for NIST26</h4>The overall procedure presented by James Little can be summarized as a short sequence:<ol><li>Obtain the original vendor LC-MS or GC-MS data.</li><li>Open the data in MSConvert or use the vendor's own conversion software.</li><li>Select mzML as the output format.</li><li>Check whether the spectra are centroided.</li><li>If necessary, add Peak Picking as the first processing filter.</li><li>Select the appropriate MS levels.</li><li>Add the file to the conversion list.</li><li>Start the conversion.</li><li>Use the resulting mzML file for NIST26 chromatogram processing.</li></ol>The procedure itself is straightforward, but the centroiding requirement is important. A file can have the correct <code>.mzML</code> extension and still be unsuitable for the workflow if its spectra remain in profile mode.<h4>From vendor data to integrated NIST26 processing</h4>File conversion may appear to be a relatively minor step compared with deconvolution, spectral interpretation, and library searching, but it establishes the foundation for the entire downstream workflow.By using mzML as the common input format, NIST26 can process data originating from different instrument platforms through a more consistent workflow. ProteoWizard and MSConvert provide a practical bridge between proprietary mass spectrometry files and this standardized format.The key message from the presentation is therefore simple: convert to mzML, ensure the spectra are centroided, and place Peak Picking first whenever centroiding is required. Once those conditions are met, the data are ready for the integrated chromatogram-processing and library-searching capabilities available in NIST26.

Conversion to mzML Format for NIST26 Chromatogram Processing

Article

Academy

Environment

Science and research

Software

Video

A unique company dedicated to serving science helping our customers drive productivity and accelerate results. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services.

Thermo Fisher Scientific

In 1936, the Laboratory Equipment Company introduced the first rapid carbon determinator for the American iron and steel industry.  Today, almost 80 years later, LECO is recognized globally as a leader in the development of high-quality analytical instrumentation, mass spectrometers, comprehensive two-dimensional chromatography, metallography & optical equipment as well as consumables.

LECO

My main interest is the identification of organic compounds by mass spectrometry in organic mixtures.

James Little/Mass Spec Interpretation Services

Watrex application and R&D laboratory

Watrex application and R&D laboratory is providing a range of analyses.

Watrex application and R&amp;D laboratory is providing a range of analyses with special focus in the following fields:<ul><li>Chemical analysis for construction industry</li><li>Environmental analysis</li><li>Sample preparation including online solid-phase extraction protocols</li><li>Development of methods for pharmaceutical analysis</li><li>Characterization of synthetic polymers by GPC</li><li>Column technology and methods for chiral separation</li><li>Parameters evaluation and testing in ion chromatography applications</li></ul><h5>Our ready-to-go tests include:</h5><ul><li>Analysis of carbohydrates</li><li>Characterization of polymers</li><li>Analysis of organic acids</li><li>Construction analysis</li><li>Analysis of ions, pH and water hardness</li></ul>

Blind common anabolic steroid and aromatase inhibitors screening – raws

Blind HPLC screening of common anabolic steroids and aromatase inhibitors in raw API powders. The analysis identifies the target compound and determines its percentage content.

The Blind Common Anabolic Steroid and Aromatase Inhibitor Screening is a comprehensive laboratory analysis designed to identify and quantify commonly encountered anabolic-androgenic steroids and aromatase inhibitors in raw active pharmaceutical ingredient (API) powders.Because this is a blind analysis, there is no need to specify which substance is expected in the sample. The analysis screens for all target compounds listed below and identifies and quantifies any detected substance.<h4>About the Target Compounds</h4>Anabolic-androgenic steroids are synthetic derivatives of testosterone or structurally related steroid hormones. They interact with androgen receptors and produce both anabolic effects, associated with tissue and muscle growth, and androgenic effects. The screening covers testosterone and nandrolone esters, trenbolone derivatives, drostanolone esters, boldenone undecylenate, trestolone acetate, dihydroboldenone cypionate, and several other commonly encountered anabolic steroids.Esterification modifies properties such as solubility and the rate at which a steroid is released after administration. For this reason, the panel includes multiple ester forms of testosterone, trenbolone, nandrolone, drostanolone, methenolone, and other steroid compounds.Letrozole, anastrozole, and exemestane are aromatase inhibitors. They inhibit aromatase, the enzyme involved in estrogen biosynthesis, thereby reducing estrogen production. Letrozole and anastrozole are non-steroidal aromatase inhibitors, whereas exemestane is a steroidal inhibitor.<h4>Key Features</h4><ul><li>Blind screening with no need to declare the expected compound</li><li>Identification of common anabolic steroids and aromatase inhibitors in raw API powders</li><li>Broad panel covering steroid bases, esters, and aromatase inhibitors</li><li>Quantification of the detected target compound</li><li>Analysis by HPLC</li><li>Results reported as percentage content</li><li>Average turnaround time of 7 business days</li><li>Minimum sample amount of 200 mg of raw powder</li></ul><h4>Analysis Parameters</h4><ul><li>Target compounds: testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, testosterone enanthate, testosterone cypionate, testosterone decanoate, trenbolone base, trenbolone acetate, trenbolone enanthate, trenbolone hexahydrobenzylcarbonate, trestolone acetate, nandrolone phenylpropionate, nandrolone decanoate, drostanolone propionate, drostanolone enanthate, dihydroboldenone cypionate, boldenone undecylenate, letrozole, anastrozole, dihydrotestosterone (DHT), exemestane, fluoxymesterone, methandrostenolone, oxandrolone, stanozolol, 4-chlorodehydromethyltestosterone, mesterolone, methasterone, oxymetholone, methenolone acetate, methenolone enanthate, and testosterone base</li><li>Other common names and brand names: Andriolos, Parabolan, MENT, NPP, Deca, BU, Equipoise, EQ, Parenabol, Femara, Arimidex, Aromasin, Halotestin, Halo, Anavar, Var, Winstrol, Turinabol, Proviron, Anadrol, Anapolon, Primobolan, Test E, Test C, Methandienone, Dianabol, and Dbol</li><li>Testing method: HPLC</li><li>Detection limit cutoff: 50%</li><li>Result format: % [98%+, 96%+ or % value such as 94.15%]</li><li>Minimum sample amount: 200 mg of raw powder</li><li>Average turnaround time: 7 business days</li></ul><blockquote>Important Notice: The detection cutoff is 50%. Samples containing a target compound below this level may therefore fall outside the standard scope of the screening.</blockquote><h4>Optional Additional Analyses</h4>The following optional laboratory services are available:<ul><li>Complete Raw Analytical Data</li><li>Fentanyl Screening</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/2524">GC–MS Contamination Screening</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/products/2525">Heavy Metals Analysis (As, Cd, Pb, Hg)</a></li><li>Additional Laboratory Report</li></ul>

Blind common anabolic steroid screening – ID only

Blind HPLC identification of common anabolic steroids and selected aromatase inhibitors in oils, oral products, and raw API powders. The analysis reports the detected compound without quantification.

The Blind Common Anabolic Steroid Screening – ID Only is a laboratory analysis designed to identify commonly encountered anabolic-androgenic steroids and selected aromatase inhibitors in an unknown sample. The test is suitable for oil-based samples, oral dosage forms such as tablets and capsules, and raw active pharmaceutical ingredient (API) powders.Because this is a blind analysis, there is no need to specify which substance is expected in the sample. The analysis screens for all target compounds listed below and reports the identity of the detected compound.<h4>About the Target Compounds</h4>Anabolic-androgenic steroids are synthetic derivatives of testosterone or structurally related steroid hormones. They interact with androgen receptors and produce both anabolic effects, associated with tissue and muscle growth, and androgenic effects.The analysis covers testosterone, trenbolone, nandrolone, drostanolone, methenolone, boldenone, and other commonly encountered anabolic steroids. It includes both non-esterified steroid bases and esterified forms, which differ in properties such as solubility and release rate after administration.The screening also includes letrozole, anastrozole, and exemestane. These compounds are aromatase inhibitors that reduce estrogen production by inhibiting the aromatase enzyme. Letrozole and anastrozole are non-steroidal inhibitors, whereas exemestane is a steroidal aromatase inhibitor.<h4>Key Features</h4><ul><li>Blind identification with no need to declare the expected compound</li><li>Identification of common anabolic steroids and selected aromatase inhibitors</li><li>Suitable for oil-based samples, tablets, capsules, and raw API powders</li><li>Broad selection of steroid bases and esterified compounds</li><li>Analysis by HPLC</li><li>Results reported as the name of the detected compound</li><li>Average turnaround time of 7 business days</li><li>Minimum sample requirements adapted to the submitted sample type</li></ul><h4>Analysis Parameters</h4><ul><li>Target compounds: testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, testosterone enanthate, testosterone cypionate, testosterone decanoate, trenbolone base, trenbolone acetate, trenbolone hexahydrobenzylcarbonate, trestolone acetate, nandrolone phenylpropionate, nandrolone decanoate, drostanolone propionate, drostanolone enanthate, dihydroboldenone cypionate, boldenone undecylenate, letrozole, anastrozole, exemestane, fluoxymesterone, methandrostenolone, oxandrolone, stanozolol, 4-chlorodehydromethyltestosterone, mesterolone, methasterone, oxymetholone, methenolone acetate, methenolone enanthate, and testosterone base</li><li>Testing method: HPLC</li><li>Result format: Name of the AAS found in the sample</li><li>Minimum sample amount&nbsp;<ul><li>oils: 0.5–1 mL</li><li>oral products: One tablet or capsule</li><li>raw powders: 200 mg</li></ul></li><li>Average turnaround time: 7 business days</li></ul><blockquote>Important Notice: This analysis provides compound identification only. The amount, concentration, or percentage content of the detected substance is not measured.</blockquote><h4>Optional Additional Analyses</h4>The following optional laboratory services are available:<ul><li>Fentanyl Screening</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/2524">GC–MS Contamination Screening</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/products/2525">Heavy Metals Analysis (As, Cd, Pb, Hg)</a></li><li>Additional Laboratory Report</li></ul>

Blind common anabolic steroid screening – oils

Blind HPLC screening of common anabolic steroids in oil-based samples. The analysis identifies and quantifies all detected target compounds, including mixtures.

The Blind Common Anabolic Steroid Screening – Oils is a comprehensive laboratory analysis designed to identify and quantify commonly encountered anabolic-androgenic steroids in oil-based samples.Because this is a blind analysis, there is no need to specify which substance is expected in the sample. The analysis screens for all target compounds listed below and identifies and quantifies every detected substance, including samples containing mixtures of multiple compounds.<h4>About the Target Compounds</h4>Anabolic-androgenic steroids are synthetic derivatives of testosterone or structurally related steroid hormones. They interact with androgen receptors and produce both anabolic effects, associated with tissue and muscle growth, and androgenic effects.The analysis covers several esterified forms of testosterone, trenbolone, nandrolone, drostanolone, methenolone, and boldenone, as well as testosterone undecanoate, methyltestosterone, trestolone acetate, and dihydrotestosterone (DHT).Esterification influences properties such as solubility and the rate at which a steroid is released after administration. Different ester forms of the same steroid may therefore differ in their physicochemical and pharmacokinetic characteristics.<h4>Key Features</h4><ul><li>Blind screening with no need to declare the expected compound</li><li>Identification and quantification of common anabolic steroids in oil-based samples</li><li>Detection of mixtures containing multiple target compounds</li><li>Broad range of steroid bases and esterified compounds</li><li>Analysis by HPLC</li><li>Results reported in mg/mL</li><li>Average turnaround time of 7 business days</li><li>Minimum sample amount of 0.5–1 mL of oil</li></ul><h4>Analysis Parameters</h4><ul><li>Target compounds: testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, testosterone enanthate, testosterone cypionate, testosterone decanoate, testosterone undecanoate, methyltestosterone, trenbolone acetate, trenbolone enanthate, trenbolone hexahydrobenzylcarbonate, trestolone acetate, dihydrotestosterone (DHT), nandrolone phenylpropionate, nandrolone cypionate, nandrolone decanoate, drostanolone propionate, drostanolone enanthate, dihydroboldenone cypionate, methenolone enanthate, boldenone acetate, boldenone cypionate, and boldenone undecylenate</li><li>Other common names and brand names: Sustanon, Test E, Test C, Deca, Tren, Parabolan, MENT, NPP, Masteron, Masteron Propionate, Mast P, Masteron Enanthate, Mast E, Primobolan, Primo E, BU, Equipoise, EQ, and Parenabol</li><li>Testing method: HPLC</li><li>Detection limit cutoff:&nbsp;<ul><li>15 mg/mL</li><li>drostanolone propionate and drostanolone enanthate: 25 mg/mL</li></ul></li><li>Result format: mg/mL</li><li>Minimum sample amount: 0.5–1 mL of oil</li><li>Average turnaround time: 7 business days</li></ul><blockquote>Important Notice: The standard detection cutoff is 15 mg/mL. For drostanolone propionate and drostanolone enanthate, the cutoff is 25 mg/mL. Target compounds present below these levels may not be reliably detected or quantified within the standard scope of the analysis.</blockquote><h4>Optional Additional Analyses</h4>The following optional laboratory services are available:<ul><li>Benzyl Alcohol and Benzyl Benzoate Testing</li><li>Complete Raw Analytical Data</li><li>Fentanyl Screening</li><li>pH Measurement</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/2524">GC–MS Contamination Screening</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/2527">Sterility Testing (TAMC and TYMC)</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/products/2525">Heavy Metals Analysis (As, Cd, Pb, Hg)</a></li><li>Additional Laboratory Report</li></ul>

DHT enanthate analysis

Targeted HPLC analysis of DHT enanthate in oil-based samples and raw API powders. The test confirms compound identity and determines its content in mg/mL or percentage.

The DHT Enanthate Analysis is a targeted laboratory test designed to confirm the identity and determine the amount of dihydrotestosterone enanthate in oil-based samples and raw active pharmaceutical ingredient (API) powders.The analysis specifically targets DHT enanthate. Samples expected to contain non-esterified DHT should instead be submitted for the appropriate blind common anabolic steroid screening for <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/2478">oils </a>or<a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/2476"> raw API powders</a>.<h4>About DHT Enanthate</h4>DHT enanthate, also known as dihydrotestosterone heptanoate, is an esterified form of DHT designed for slower release and potentially prolonged activity. The enanthate group increases the compound’s lipophilicity. After release, DHT activates androgen receptors and, unlike testosterone, cannot be converted into estradiol by aromatase.<h4>Key Features</h4><ul><li>Targeted identification and quantification of DHT enanthate</li><li>Suitable for oil-based samples and raw API powders</li><li>Analysis by HPLC</li><li>Results for oil samples reported in mg/mL</li><li>Results for raw API powders reported as percentage content</li><li>Optional mass-by-mass purity reporting for raw API powders</li><li>Minimum sample amount of 0.5–1 mL for oil samples</li><li>Minimum sample amount of 200 mg for raw API powders</li><li>Average turnaround time of 7 business days</li></ul><h4>Analysis Parameters</h4><ul><li>Target compound: DHT enanthate</li><li>Testing method: HPLC</li><li>Detection limit cutoff: 15 mg/mL</li><li>Result format for oil samples: mg/mL</li><li>Minimum sample amount for oil samples: 0.5–1 mL</li><li>Result format for raw API powders: % [98%+, 96%+ or % value such as 94.15%]</li><li>Minimum sample amount for raw API powders: 200 mg</li><li>Average turnaround time: 7 business days</li></ul><blockquote>Important Notice: This analysis is intended specifically for DHT enanthate. It is not designed for the analysis of non-esterified DHT.</blockquote><h4>Optional Additional Analyses</h4>The following optional laboratory services are available:<ul><li>Benzyl Alcohol and Benzyl Benzoate Testing</li><li>Complete Raw Analytical Data</li><li>Alternative Result Format: Mass-by-Mass Purity - only for raw API powders</li><li>pH Measurement</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/2524">GC–MS Contamination Screening</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/2527">Sterility Testing (TAMC and TYMC)</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/products/2525">Heavy Metals Analysis (As, Cd, Pb, Hg)</a></li><li>Additional Laboratory Report</li></ul>

Epistane analysis

Targeted HPLC analysis of epistane in tablets, capsules, and raw API powders. The test confirms compound identity and determines its content in mg per unit or as a percentage.

The Epistane Analysis is a targeted laboratory test designed to confirm the identity and determine the amount of epistane in oral dosage forms and raw active pharmaceutical ingredient (API) powders.&nbsp;The analysis is suitable for tablets and capsules, with results reported in milligrams per individual dosage unit. Raw API powders can be evaluated by percentage content, with optional purity reporting in % (m/m).<h4>About Epistane</h4>Epistane, also known as methylepitiostanol or 2,3-thioepoxy madol, is a synthetic, orally active anabolic-androgenic steroid structurally related to dihydrotestosterone (DHT). It is a 17α-methylated derivative of epitiostanol and interacts with androgen receptors, producing anabolic and androgenic effects.Epistane has been identified in products marketed as dietary or performance-enhancing supplements. Scientific studies have also associated its use with a risk of liver injury, including cholestasis.<h4>Key Features</h4><ul><li>Targeted identification and quantification of epistane</li><li>Suitable for tablets, capsules, and raw API powders</li><li>Analysis by HPLC</li><li>Results for oral products reported in mg per tablet or capsule</li><li>Results for raw API powders reported as percentage content</li><li>Optional purity reporting in % (m/m) for raw API powders</li><li>Minimum sample amount of three tablets or capsules</li><li>Minimum sample amount of 200 mg for raw API powders</li><li>Average turnaround time of 7 business days</li></ul><h4>Analysis Parameters</h4><ul><li>Target compound: Epistane</li><li>Other names: Hemapolin, 2,3-thioepoxy madol</li><li>CAS number: 4267-80-5</li><li>Testing method: HPLC</li><li>Minimum amount of target compound for evaluation in oral products: 4 mg per tablet / capsule</li><li>Minimum content of target compound for evaluation in raw API powders: 10%</li><li>Result format for oral products: mg per tablet or capsule</li><li>Result format for raw API powders: % [98%+, 96%+ or % value such as 94.15%]</li><li>Minimum sample amount for oral products: 3 tablets / capsules</li><li>Minimum sample amount for raw API powders: 200 mg</li><li>Average turnaround time: 7 business days</li></ul><h4>Optional Additional Analyses</h4>The following optional laboratory services are available:<ul><li>Complete Raw Analytical Data</li><li>Alternative Result Format: Purity in % (m/m) - only for raw API powders</li><li>Batch Variance Testing</li><li>Fentanyl Screening</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/2524">GC–MS Contamination Screening</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/products/2525">Heavy Metals Analysis (As, Cd, Pb, Hg)</a></li><li>Additional Laboratory Report</li></ul>

Products focused on Laboratory analysis - page 13

Related content

Oligonucleotide and mRNA Analysis Resource Roundup

Conversion to mzML Format for NIST26 Chromatogram Processing

Surpassing the Limits of Traditional Microplastic Analysis Methods with Thermal Desorption and Pyrolysis GCxGC-TOFMS